This inventor holds 1 USPTO granted patent. Top assignee: Alnylam Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Eric Chiao
Introduction
Eric Chiao is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of biotechnology, particularly in the area of genetic research. His work has implications for understanding various genetic disorders and advancing therapeutic methods.
Latest Patents
Eric Chiao holds a patent titled "Human Chromosome 9 Open Reading Frame 72 (C9ORF72) iRNA Agent Compositions and Methods of Use Thereof." This patent represents his innovative approach to utilizing RNA interference technology to target specific genetic sequences, which could lead to breakthroughs in treating diseases associated with the C9ORF72 gene.
Career Highlights
Chiao is currently employed at Alnylam Pharmaceuticals, Inc., a leading company in the development of RNAi therapeutics. His role at Alnylam has allowed him to collaborate with some of the brightest minds in the industry, contributing to the advancement of cutting-edge treatments.
Collaborations
One of his notable coworkers is Elane Fishilevich. Together, they work on projects that aim to harness the power of RNA interference for therapeutic applications.
Conclusion
Eric Chiao's contributions to biotechnology and his innovative patent highlight his role as a key figure in the field. His work continues to pave the way for advancements in genetic research and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile